Holen Sie sich die Stockscreener-App
0.9207
2.30%
0.0207
Vorhandelsmarkt:
.94
0.0193
+2.10%
Schlusskurs vom Vortag:
$0.90
Offen:
$0.9
24-Stunden-Volumen:
252.51K
Relative Volume:
1.06
Marktkapitalisierung:
$43.12M
Einnahmen:
$10.85M
Nettoeinkommen (Verlust:
$-51.31M
KGV:
-1.2493
EPS:
-0.737
Netto-Cashflow:
$-36.77M
1W Leistung:
-7.93%
1M Leistung:
-19.24%
6M Leistung:
-53.50%
1J Leistung:
-64.04%
1-Tages-Spanne:
$0.8951
$0.9998
1-Wochen-Bereich:
$0.8639
$1.00
52-Wochen-Spanne:
$0.8639
$2.9319
InspireMD Inc. Stock (NSPR) Company Profile
Firmenname
InspireMD Inc.
Sektor
Branche
Telefon
972 3 6917691
Adresse
4 Menorat Hamaor Street, Tel Aviv
Compare NSPR vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NSPR
InspireMD Inc.
|
0.9207 | 42.16M | 10.85M | -51.31M | -36.77M | -0.737 |
ABT
Abbott Laboratories
|
85.60 | 150.32B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
305.09 | 117.93B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
73.81 | 97.02B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
48.31 | 72.99B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.47 | 49.50B | 6.30B | 1.07B | 1.09B | 1.8406 |
InspireMD Inc. Stock (NSPR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-02 | Eingeleitet | Maxim Group | Buy |
| 2016-01-07 | Eingeleitet | Rodman & Renshaw | Buy |
| 2015-03-13 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2013-11-26 | Eingeleitet | Oppenheimer | Outperform |
InspireMD Inc. Aktie (NSPR) Neueste Nachrichten
InspireMD director Paul Stuka buys $17,500 in shares - Investing.com
Director Paul Stuka buys 20,000 InspireMD (NSPR) shares in open-market trade - Stock Titan
InspireMD anticipates FDA approval of original CGuard delivery system in Q3 2026 as it withdraws 2026 revenue guidance - MSN
InspireMD (NSPR) Slides 7.9% as Stock Tests Key Support Near $0.84RVOL Spike - thelegaladvocate.com
InspireMD (NSPR) Q1 2026 Earnings: EPS Beat Despite Net Loss, Shares Dip 2.9%Post-Announcement Reaction - Newser
Paul Stuka to Retire from InspireMD Board, Will Not Seek Re‑election - TradingView
InspireMD (NSPR) chair Paul Stuka plans Board retirement in 2027 - Stock Titan
NSPR Technical Analysis | Trend, Signals & Chart Patterns | INSPIREMD INC (NASDAQ:NSPR) - ChartMill
NSPR Q1 2026 Earnings: Loss Narrower Than Expected as InspireMD Advances Commercial PipelineProfit Growth Outlook - Newser
InspireMD CCO Shane Gleason sells $189,594 in stock By Investing.com - Investing.com Canada
InspireMD CCO Shane Gleason sells $189,594 in stock - Investing.com
InspireMD (NSPR) CCO auto-sells shares to cover RSU tax obligations - Stock Titan
InspireMD (NSPR) price target decreased by 13.33% to 4.42 - MSN
Nantahala reports 4.82M shares in InspireMD (NSPR) including convertibles - Stock Titan
Director Stuka increases InspireMD (NSPR) stake with 15,000-share buys - Stock Titan
Velan Capital holds 4.99% of InspireMD (NASDAQ: NSPR) via 2.35M shares - Stock Titan
TradingKey - TradingKey
InspireMD CEO Marvin Slosman buys $25,200 in company stock By Investing.com - Investing.com Australia
InspireMD Inc (NSPR) CEO Marvin Slosman Increases Stake with Rec - GuruFocus
NSPR: Endovascular stenting for carotid disease is accelerating, backed by best-in-class clinical results - TradingView
InspireMD CEO Marvin Slosman buys $25,200 in company stock - Investing.com UK
InspireMD (NSPR) CEO adds 21,000 shares in $1.20 open-market buy - Stock Titan
InspireMD (NSPR) director boosts stake with 75,626-share buy, corrects 10b5-1 and ownership details - Stock Titan
InspireMD director Paul Stuka buys $88,026 in shares - Investing.com UK
InspireMD director Paul Stuka buys $88,026 in shares By Investing.com - Investing.com South Africa
InspireMD (NSPR) director Paul Stuka adds 75,626 shares in open-market buys - Stock Titan
InspireMD Balances Fast Growth With U.S. Setback - TipRanks
MSN Money - MSN
InspireMD (NSPR) Q2 2025 Earnings Transcript - AOL.com
InspireMD (NSPR) Q3 2025 Earnings Transcript - AOL.com
InspireMD director Ward R. buys $102,637 in company stock By Investing.com - Investing.com Australia
Insider Buying: InspireMD (NYSE:NSPR) Director Acquires 15,995 Shares of Stock - MarketBeat
Insider Buying: InspireMD (NYSE:NSPR) Director Acquires 73,255 Shares of Stock - MarketBeat
InspireMD director Ward R. buys $102,637 in company stock - Investing.com India
InspireMD director Gary Roubin buys $106,200 in company stock - Investing.com UK
[Form 4] InspireMD, Inc. Insider Trading Activity - Stock Titan
InspireMD director Gary Roubin buys $106,200 in company stock By Investing.com - Investing.com Nigeria
Gary Roubin Buys 90,000 Shares of InspireMD (NYSE:NSPR) Stock - MarketBeat
Finanzdaten der InspireMD Inc.-Aktie (NSPR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.59%
1.94%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):